ReviewCureus2025
Comparing the Effectiveness of Antidepressants and Cognitive Behavioural Therapy in Preventing Postnatal Depression: A Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postnatal depression (PND) is a prevalent depressive disorder frequently accompanied by anxiety, with significant implications for maternal health and infant development. This systematic review compared the effectiveness of antidepressant medications and cognitive behavioural therapy (CBT) in the treatment of PND. A systematic search of PubMed and Medline was conducted on November 20, 2019, in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, and randomized controlled trials (RCTs) published between 1997 and 2019 were included. Four RCTs (N = 421) conducted in the UK, USA and Australia met the eligibility criteria. At four weeks, women treated with selective serotonin reuptake inhibitors (SSRIs) demonstrated significantly greater reductions in anxiety symptoms compared to those receiving CBT (95% confidence interval (CI): 1.8-6.5; p < 0.001), with sustained improvement at 18 weeks (95% CI: -3.3 to -0.9; p < 0.001). Conversely, CBT was associated with a faster decline in anxiety symptoms after 12 weeks (p = 0.009). Both interventions achieved significant overall clinical improvements (p < 0.01), while combined therapy did not confer additional benefits beyond monotherapy. These findings suggest that SSRIs may provide superior short-term and sustained relief of anxiety symptoms, whereas CBT may support longer-term symptom control. Therefore, treatment selection should consider symptom severity, potential side effects, breastfeeding and patient preferences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.